Skip to content

Clinical trials

Hypertension trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Country / region: Russia Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20047
20054
20062
20077
20085
20097
20102
20113
20126
20138
20143
20153
20161
20171
20188
20193
20203
20215
20223
20233
20246
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Unknown status9
Terminated5
Recruiting2
Not yet recruiting2
Enrolling by invitation2
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
AstraZeneca6
Boehringer Ingelheim6
I.M. Sechenov First Moscow State Medical University6
Meshalkin Research Institute of Pathology of Circulation6
Servier Russia5
Bristol-Myers Squibb4
National Medical Research Center for Therapy and Preventive Medicine4
Takeda4
Tomsk National Research Medical Center of the Russian Academy of Sciences4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension95
Atrial Fibrillation9
Diabetes Mellitus9
Cardiovascular Diseases6
Heart Failure6
Dyslipidemias5
Obesity5
Coronary Artery Disease4
Renal Insufficiency, Chronic4
COVID-193

Trials

Showing 51 to 75 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.